Thyroid C-cell Tumors: In rodent studies, semaglutide is revealed to trigger thyroid C-cell tumors. It's unfamiliar whether or not this danger relates to individuals, but semaglutide is contraindicated in patients with a personal or household heritage of medullary thyroid carcinoma (MTC) or clients with Many Endocrine Neoplasia syndrome sort 2 (MEN